Droroloxifene , a new antiestrogen in advanced breast cancer, double blind dose finding study (1991)
- Authors:
- Autor USP: HEGG, ROBERTO - FM
- Unidade: FM
- Assunto: ONCOLOGIA
- Language: Inglês
- Source:
- Título do periódico: European Journal of Cancer
- Volume/Número/Paginação/Ano: v.27, n.2 supl., p.s55, 1991
- Conference titles: European Conference on Clinical Oncology and Cancer Nursing
-
ABNT
CHEVALLIER, B; BROWN, C; BRUNING, P F; et al. Droroloxifene , a new antiestrogen in advanced breast cancer, double blind dose finding study. European Journal of Cancer[S.l: s.n.], 1991. -
APA
Chevallier, B., Brown, C., Bruning, P. F., Deschenes, L., Hegg, R., Malzyner, A., et al. (1991). Droroloxifene , a new antiestrogen in advanced breast cancer, double blind dose finding study. European Journal of Cancer. -
NLM
Chevallier B, Brown C, Bruning PF, Deschenes L, Hegg R, Malzyner A, Marschner N, Paterson A, Prichard KI, Serin D, Spielmann M. Droroloxifene , a new antiestrogen in advanced breast cancer, double blind dose finding study. European Journal of Cancer. 1991 ;27( 2 supl.): s55. -
Vancouver
Chevallier B, Brown C, Bruning PF, Deschenes L, Hegg R, Malzyner A, Marschner N, Paterson A, Prichard KI, Serin D, Spielmann M. Droroloxifene , a new antiestrogen in advanced breast cancer, double blind dose finding study. European Journal of Cancer. 1991 ;27( 2 supl.): s55. - Recursos terapêuticos na doente terminal
- Everolimus (EVE) plus letrozole (LET) in patients (pts) with estrogen receptor-positive (ER plus ), human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (ABC): Progression-free survival (PFS) subgroup analyses in BOLERO-4
- Adjuvant denosumab in early breast cancer (D-CARE): an international, multicentre, randomised, controlled, phase 3 trial
- Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer
- Câncer de mama
- Hormonioterapia de reposicao e cancer de mama
- Prevencao da osteoporose
- Como diagnosticar e tratar sindrome do climaterio
- Galactorreia: sindrome hiperprolactinemica
- Distrofias vulvares
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
